Form 4: Oxbridge Re Holdings CFO Timothy Wrendon Reports Share Grant and Option Holdings

Sentiment:

SEC Form 4


Oxbridge Re Holdings CFO Timothy Wrendon reported the acquisition of 25,000 ordinary shares and provided an update on his holdings of share options and warrants.

Summary

  • On March 25, 2024, Timothy Wrendon, CFO & Secretary of Oxbridge Re Holdings Ltd, acquired 25,000 ordinary shares at $0, representing a grant under the Issuer's 2021 Omnibus Incentive Plan.
  • Following this transaction, Wrendon directly owns 75,050 ordinary shares.
  • Wrendon also holds various share options with exercise prices ranging from $2 to $6.06, vesting quarterly over a four-year period.
  • He also holds warrants to purchase 7,500 ordinary shares at $7.50, which are currently exercisable.

Sentiment

Score: 6

Explanation: The document is a standard regulatory filing, so the sentiment is neutral. The grant of shares could be seen as a positive sign of confidence in the company's future, but it's a routine part of executive compensation.

Positives

  • The grant of restricted ordinary shares under the Issuer's 2021 Omnibus Incentive Plan suggests a continued commitment to aligning management's interests with those of shareholders.

Industry Context

This filing is a routine disclosure related to insider transactions and is typical for publicly traded companies. It provides transparency regarding the holdings and transactions of company executives.

Comparison to Industry Standards

  • Executive compensation packages often include a mix of salary, stock options, and restricted stock units (RSUs).
  • The vesting schedule of the share options (quarterly over four years) is a common practice to incentivize long-term performance.
  • Companies like RenaissanceRe, Everest Re, and Arch Capital Group also utilize similar equity-based compensation strategies for their executives.

Stakeholder Impact

  • The transaction provides transparency to shareholders regarding executive compensation and ownership.

Key Dates

DateDescription
01/16/2026Expiration date for share options with a $6 exercise price.
01/20/2027Expiration date for share options with a $6.06 exercise price.
03/16/2029Expiration date for share options with a $2 exercise price.
03/26/2029Expiration date for warrants to purchase ordinary shares at $7.50.
03/02/2031Expiration date for share options with a $6 exercise price.
01/09/2023Date of Earliest Transaction
03/25/2024Date of ordinary shares acquisition.
04/16/2024Date of signature.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.